<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>us-ein-522044704-NewVaccinesForTB</iati-identifier>
  <reporting-org ref="US-EIN-522044704" type="21">
   <narrative xml:lang="EN">Aeras</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Aeras Product Development Partnership Programme 2013 to 2018: New Vaccines for Tuberculosis</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">AERAS PRODUCT DEVELOPMENT PARTNERSHIP PROGRAMME 2013 TO 2018: NEW VACCINES FOR TUBERCULOSIS</narrative>
  </description>
  <participating-org ref="us-ein-522044704" role="2" type="21">
   <narrative xml:lang="EN">Aeras</narrative>
  </participating-org>
  <participating-org ref="us-ein-522044704" role="3" type="21">
   <narrative xml:lang="EN">Aeras</narrative>
  </participating-org>
  <participating-org ref="us-ein-522044704" role="4" type="21">
   <narrative xml:lang="EN">Aeras</narrative>
  </participating-org>
  <participating-org role="1" type="60">
   <narrative xml:lang="EN">Bill and Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="EN">Department for International Development - GOV.UK</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="EN">Directorate-General for International Cooperation (DGIS)</narrative>
  </participating-org>
  <participating-org role="1" type="15">
   <narrative xml:lang="EN">GlaxoSmithKline</narrative>
  </participating-org>
  <participating-org role="1" type="15">
   <narrative xml:lang="EN">Sanofi</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2013-04-01" type="2">
   <narrative xml:lang="EN">New Vaccines for Tuberculosis</narrative>
  </activity-date>
  <recipient-country code="CN" percentage="1">
   <narrative xml:lang="EN">This includes Aeras&apos; China Office</narrative>
  </recipient-country>
  <recipient-country code="ZA" percentage="32">
   <narrative xml:lang="EN">This includes Aeras&apos; South Africa Office</narrative>
  </recipient-country>
  <recipient-country code="US" percentage="62">
   <narrative xml:lang="EN">This includes Aeras&apos; US office and payments sent to partners across United States</narrative>
  </recipient-country>
  <recipient-country code="AU" percentage="1">
   <narrative xml:lang="EN">This includes partners in Australia</narrative>
  </recipient-country>
  <recipient-country code="IE" percentage="1">
   <narrative xml:lang="EN">This includes partners in Ireland</narrative>
  </recipient-country>
  <recipient-country code="NL" percentage="1">
   <narrative xml:lang="EN">This includes partners in Netherlands</narrative>
  </recipient-country>
  <recipient-country code="GB" percentage="2">
   <narrative xml:lang="EN">This includes partners in United Kingdom</narrative>
  </recipient-country>
  <sector code="12182" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Aeras</narrative>
  </sector>
  <collaboration-type code="3"></collaboration-type>
  <default-finance-type code="110"></default-finance-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-31"></period-end>
   <value currency="USD" value-date="2016-01-01">43246584</value>
  </budget>
  <transaction humanitarian="0" ref="DFID-2014-1">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2014-04-01"></transaction-date>
   <value currency="USD" value-date="2014-04-01">2156244.82</value>
   <description>
    <narrative xml:lang="EN">2nd installment for the DFID award</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="DFID-2014-2">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2014-08-06"></transaction-date>
   <value currency="USD" value-date="2014-08-06">1593459.7</value>
   <description>
    <narrative xml:lang="EN">3rd installment for the DFID award</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="DFID-2014-3">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2014-11-26"></transaction-date>
   <value currency="USD" value-date="2014-11-26">1484513.7</value>
   <description>
    <narrative xml:lang="EN">3rd installment for the DFID award</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="DFID-2015-1">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2015-07-06"></transaction-date>
   <value currency="USD" value-date="2015-07-06">1200720</value>
   <description>
    <narrative xml:lang="EN">5th installment for the DFID award</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="DFID-2015-2">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2015-12-07"></transaction-date>
   <value currency="USD" value-date="2015-12-07">1176151.2</value>
   <description>
    <narrative xml:lang="EN">6th installment for the DFID award</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="DFID-2016-2">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2016-11-29"></transaction-date>
   <value currency="USD" value-date="2016-11-29">977680</value>
   <description>
    <narrative xml:lang="EN">8th installment for the DFID award</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="Invoice 2017/002">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-08-21"></transaction-date>
   <value currency="USD" value-date="2017-08-21">7666.29</value>
   <description>
    <narrative xml:lang="EN">A-050 GMO submission</narrative>
   </description>
  </transaction>
  <transaction humanitarian="0" ref="APRef308573">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-11-26"></transaction-date>
   <value currency="USD" value-date="2014-11-26">500000</value>
   <description>
    <narrative xml:lang="EN">Agreement with TBVI to undertake clinical and preclinical activities approved by the Aeras Internal Portfolio Review Committee</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">TuBerculosis Vaccine Initiative (TBVI)</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058497">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-19"></transaction-date>
   <value currency="USD" value-date="2014-03-19">15810.5</value>
   <description>
    <narrative xml:lang="EN">Animal Study Project</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">Colorado State University</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef059089">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-04-17"></transaction-date>
   <value currency="USD" value-date="2014-04-17">19763</value>
   <description>
    <narrative xml:lang="EN">Animal Study Project</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">Colorado State University</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058787">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-27"></transaction-date>
   <value currency="USD" value-date="2014-03-27">179348.8</value>
   <description>
    <narrative xml:lang="EN">Animal Study agreement with the University</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">The University of Pittsburgh</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058429">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-11"></transaction-date>
   <value currency="USD" value-date="2014-03-11">10000</value>
   <description>
    <narrative xml:lang="EN">Animal Study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Trudeau Institute Inc.</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-21"></transaction-date>
   <value currency="USD" value-date="2014-03-21">62577</value>
   <description>
    <narrative xml:lang="EN">Assessment of protective efficacy of new TB Vaccines (in prime-boost combination) against TB</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="10">
    <narrative xml:lang="EN">National Institute for Biological Standards and Control</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058126">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-02-28"></transaction-date>
   <value currency="USD" value-date="2014-02-28">295.32</value>
   <description>
    <narrative xml:lang="EN">BIOS for 404-013 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Quintiles Clindepharm (Pty) Ltd.</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef060155">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-06-18"></transaction-date>
   <value currency="USD" value-date="2014-06-18">393.76</value>
   <description>
    <narrative xml:lang="EN">BIOS for 404-040 trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Quintiles Clindepharm (Pty) Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032424">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-18"></transaction-date>
   <value currency="USD" value-date="2016-07-18">3089</value>
   <description>
    <narrative xml:lang="EN">CRO Services for the 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Quintiles</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032800">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-09-27"></transaction-date>
   <value currency="USD" value-date="2016-09-27">101270</value>
   <description>
    <narrative xml:lang="EN">CRO Services for the 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Quintiles</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058922">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-26"></transaction-date>
   <value currency="USD" value-date="2014-03-26">162939.5</value>
   <description>
    <narrative xml:lang="EN">Clinical Trial Research Study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Trustees of Dartmouth College</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef060567">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-06-20"></transaction-date>
   <value currency="USD" value-date="2014-06-20">162849.5</value>
   <description>
    <narrative xml:lang="EN">Clinical Trial Research Study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Trustees of Dartmouth College</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058329">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-19"></transaction-date>
   <value currency="USD" value-date="2014-03-19">1468</value>
   <description>
    <narrative xml:lang="EN">Clinical agreement for 993-D14 study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Desmond Tutu HIV Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef054865">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-08-01"></transaction-date>
   <value currency="USD" value-date="2013-08-01">116304</value>
   <description>
    <narrative xml:lang="EN">Clinical agreement with the Institute for 993-D14 study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Infectious Disease Research Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef063262">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-12-11"></transaction-date>
   <value currency="USD" value-date="2014-12-11">112457</value>
   <description>
    <narrative xml:lang="EN">Clinical agreement with the Institute for 993-D14 study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Infectious Disease Research Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058125">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-02-28"></transaction-date>
   <value currency="USD" value-date="2014-02-28">92956</value>
   <description>
    <narrative xml:lang="EN">Clinical agreement with the University of Oxford</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">The University of Oxford</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef058753">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-05-21"></transaction-date>
   <value currency="USD" value-date="2014-05-21">39349.2</value>
   <description>
    <narrative xml:lang="EN">Clinical agreement with the University of Oxford</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">The University of Oxford</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="DFID122013">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2013-12-31"></transaction-date>
   <value currency="USD" value-date="2013-12-31">3169350</value>
   <description>
    <narrative xml:lang="EN">DFID&apos;s 2013 1st Payment in December 2013</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="DFID-2016-1">
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2016-07-05"></transaction-date>
   <value currency="USD" value-date="2016-07-05">1048155</value>
   <description>
    <narrative xml:lang="EN">DFID&apos;s 2016 1st Payment in July 2016</narrative>
   </description>
   <provider-org provider-activity-id="GB-1-204136" ref="GB-1" type="10">
    <narrative xml:lang="EN">DFID</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="Invoice Number CEN-001976">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-02-16"></transaction-date>
   <value currency="USD" value-date="2018-02-16">101269.61</value>
   <description>
    <narrative xml:lang="EN">Data Management; source document verification</narrative>
   </description>
   <receiver-org ref="Quintiles" type="15"></receiver-org>
  </transaction>
  <transaction ref="INVOICE2016/17/000172">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-25"></transaction-date>
   <value currency="USD" value-date="2017-01-25">6601</value>
   <description>
    <narrative xml:lang="EN">Database lock for EPI - prevalence study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="60"></provider-org>
   <receiver-org ref="National Institute for Medical Research" type="80"></receiver-org>
  </transaction>
  <transaction ref="Invoice Number AVGTI0221-Y2-3">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-02-27"></transaction-date>
   <value currency="USD" value-date="2018-02-27">108779</value>
   <description>
    <narrative xml:lang="EN">Development of Optimized CMV/TB Vectors</narrative>
   </description>
   <receiver-org ref="Oregon Health and Science University" type="80"></receiver-org>
  </transaction>
  <transaction ref="APRef069755">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-08-25"></transaction-date>
   <value currency="USD" value-date="2016-08-25">11944</value>
   <description>
    <narrative xml:lang="EN">Development of an ESAT-6 free interferon gamma release assay (IGRA) for use in a clinical trial assessing POI with Mtb by H56:IC31</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Cape Town</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef056325">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-11-08"></transaction-date>
   <value currency="USD" value-date="2013-11-08">3113.75</value>
   <description>
    <narrative xml:lang="EN">Digital Communication Campaign including Mining slideshow assistance and TB Unmasked video.</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Swell Creative Group</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032855">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-17"></transaction-date>
   <value currency="USD" value-date="2016-10-17">6601</value>
   <description>
    <narrative xml:lang="EN">E-024 adolescent epidemiology trial at the the NIMR Mwanza site</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Institute for Medical Research (NIMR)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032828">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-07"></transaction-date>
   <value currency="USD" value-date="2016-10-07">9626</value>
   <description>
    <narrative xml:lang="EN">E-024 adolescent epidemiology trial at the the NIMR Mwanza site</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Institute for Medical Research (NIMR)</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef060331">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-06-30"></transaction-date>
   <value currency="USD" value-date="2014-06-30">108064.5</value>
   <description>
    <narrative xml:lang="EN">Epidemiology agreement with IPB for E-021 study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="15">
    <narrative xml:lang="EN">The Institute of Pathogen Biology (IPB)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="APRef068580">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-04-15"></transaction-date>
   <value currency="USD" value-date="2016-04-15">1000</value>
   <description>
    <narrative xml:lang="EN">Ethical Clearence Fee for study entitled A Cross-sectional study to measure the prevalence of Mtb infection among adolescents in Mwanza region, Tanzania</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Institute for Medical Research (NIMR)</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec026749">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-02-07"></transaction-date>
   <value currency="USD" value-date="2014-02-07">5557.45</value>
   <description>
    <narrative xml:lang="EN">For 404-013 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Quintiles Clindepharm</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="INVOICE2016-4900009">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-12-01"></transaction-date>
   <value currency="USD" value-date="2017-02-01">250000</value>
   <description>
    <narrative xml:lang="EN">For review of clinical protocols prior for MTBVAC clinical trial Phase 1b conducted at SATVI</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="60"></provider-org>
   <receiver-org ref="TBVI"></receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef059470/69/67/68">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-05-14"></transaction-date>
   <value currency="USD" value-date="2014-05-14">35392.72</value>
   <description>
    <narrative xml:lang="EN">In-study Project, Site Management, Site Monitoring visits for 456-035 study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Triclinium Clinical Trial Project Management (Pty) Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="Internal0916-China&amp;SA">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-09-30"></transaction-date>
   <value currency="USD" value-date="2016-09-30">67504</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll and consultants for the period of 01/01/16-09/30/16 (China and South Africa)</narrative>
   </description>
   <provider-org type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="Internal0916-US">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-09-30"></transaction-date>
   <value currency="USD" value-date="2016-09-30">127619.96</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll and consultants for the period of 01/01/16-09/30/16</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">For Personnel and Consultancy</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="Internal1214-China">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-12-31"></transaction-date>
   <value currency="USD" value-date="2014-12-31">16359.59</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll, Travel, Lab supplies, Consultants for the period of 01/01/13-12/31/13 for the China location only.</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
  </transaction>
  <transaction humanitarian="0" ref="Internal1213-US">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2013-12-31"></transaction-date>
   <value currency="USD" value-date="2013-12-31">2137319</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll, Travel, Lab supplies, Consultants for the period of 01/01/13-12/31/13 for the US location only.</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
  </transaction>
  <transaction humanitarian="0" ref="Internal1214-US">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-12-31"></transaction-date>
   <value currency="USD" value-date="2014-12-31">2194476.82</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll, Travel, Lab supplies, Consultants for the period of 01/01/14-12/31/14 for the US location only</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
  </transaction>
  <transaction humanitarian="0" ref="InternalQ4Fy16-SA">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-12-31"></transaction-date>
   <value currency="USD" value-date="2016-12-31">35011.92</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll, Travel, Lab supplies, Consultants for the period of 10/01/16-12/31/16 for the SA location only.</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
  </transaction>
  <transaction humanitarian="0" ref="InternalQ4Fy16-US">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-12-31"></transaction-date>
   <value currency="USD" value-date="2016-12-31">55322.4</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll, Travel, Lab supplies, Consultants for the period of 10/01/16-12/31/16 for the US location only.</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
  </transaction>
  <transaction ref="Internal033118">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-31"></transaction-date>
   <value currency="USD" value-date="2018-03-31">24214</value>
   <description>
    <narrative xml:lang="EN">Internal Expenses including payroll, travel, consultants and insurance</narrative>
   </description>
  </transaction>
  <transaction ref="Internal122917">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-29"></transaction-date>
   <value currency="USD" value-date="2017-12-29">44634.54</value>
   <description>
    <narrative xml:lang="EN">Internal expenses including payroll, travel and consultants</narrative>
   </description>
  </transaction>
  <transaction ref="Internal033117">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-03-31"></transaction-date>
   <value currency="USD" value-date="2017-03-31">54003</value>
   <description>
    <narrative xml:lang="EN">Internal expenses including payroll, travel, consultants and insurance</narrative>
   </description>
  </transaction>
  <transaction ref="Internal063017">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-06-30"></transaction-date>
   <value currency="USD" value-date="2017-06-30">129233.47</value>
   <description>
    <narrative xml:lang="EN">Internal expenses including payroll, travel, consultants and insurance</narrative>
   </description>
  </transaction>
  <transaction ref="Internal093017">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-09-30"></transaction-date>
   <value currency="USD" value-date="2017-09-30">127660.25</value>
   <description>
    <narrative xml:lang="EN">Internal expenses including payroll, travel, consultants and insurance</narrative>
   </description>
  </transaction>
  <transaction humanitarian="0" ref="PORec032861">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-20"></transaction-date>
   <value currency="USD" value-date="2016-10-20">27345</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Cape Town</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec031803">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-02-24"></transaction-date>
   <value currency="USD" value-date="2016-02-24">44991</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Aurum</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032325">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-06-24"></transaction-date>
   <value currency="USD" value-date="2016-06-24">29543</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Aurum</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032324">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-06-24"></transaction-date>
   <value currency="USD" value-date="2016-06-24">4751</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Aurum</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032773">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-09-29"></transaction-date>
   <value currency="USD" value-date="2016-09-29">2873</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Aurum</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032850">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-17"></transaction-date>
   <value currency="USD" value-date="2016-10-17">26249</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Aurum</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032326">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-06-24"></transaction-date>
   <value currency="USD" value-date="2016-06-24">29945</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Kenya Medical Research Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032853">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-17"></transaction-date>
   <value currency="USD" value-date="2016-10-17">26442</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Kenya Medical Research Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032854">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-17"></transaction-date>
   <value currency="USD" value-date="2016-10-17">37852</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Kenya Medical Research Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032447">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-15"></transaction-date>
   <value currency="USD" value-date="2016-07-15">3599</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Setshaba Research Centre</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032446">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-15"></transaction-date>
   <value currency="USD" value-date="2016-07-15">42275</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Setshaba Research Centre</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-08-25"></transaction-date>
   <value currency="USD" value-date="2016-08-25">35637</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Setshaba Research Centre</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032858">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-17"></transaction-date>
   <value currency="USD" value-date="2016-10-17">3737</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Setshaba Research Centre</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032331">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-06-29"></transaction-date>
   <value currency="USD" value-date="2016-06-29">17029</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Cape Town</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032332">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-18"></transaction-date>
   <value currency="USD" value-date="2016-07-18">37572</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Cape Town</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032450">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-18"></transaction-date>
   <value currency="USD" value-date="2016-07-18">9079</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Cape Town</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PORec032471">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-08-01"></transaction-date>
   <value currency="USD" value-date="2016-08-01">983</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for 972-T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of Cape Town</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="Invoice#015">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-08-20"></transaction-date>
   <value currency="USD" value-date="2013-08-20">46893.06</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments for the T18 trial. This invoice was taken out of advance that was paid to ZAMBART in 08/2013. Total Payment was $ 301,404. But only $46,893 was charged to DFID.</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Zambart</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec033310-13">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-17"></transaction-date>
   <value currency="USD" value-date="2017-01-17">67450.88</value>
   <description>
    <narrative xml:lang="EN">Investigator Payments fot T18 Trial</narrative>
   </description>
   <provider-org provider-activity-id="us-ein-522044704-NewVaccinesForTB" ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aurum Institute NPC, South Africa</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec033016">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-17"></transaction-date>
   <value currency="USD" value-date="2017-01-17">20120.7</value>
   <description>
    <narrative xml:lang="EN">Investigator payments to KEMRI for T18 trial. Total payment was $63,244.80. Only $20,120.70 was charged to DFID</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="15">
    <narrative xml:lang="EN">Kenya Medical Research Institute (KEMRI)</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec033078">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-11-21"></transaction-date>
   <value currency="USD" value-date="2016-11-21">76152.15</value>
   <description>
    <narrative xml:lang="EN">Investigator payments to TASK Applied Science for the T18 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">TASK Applied Science</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef053904">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-06-05"></transaction-date>
   <value currency="USD" value-date="2013-06-05">1390.21</value>
   <description>
    <narrative xml:lang="EN">Laboratory work for the D-13 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">PPD Global</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef059216">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-04-30"></transaction-date>
   <value currency="USD" value-date="2014-04-30">16831.33</value>
   <description>
    <narrative xml:lang="EN">MCC and Ethics application for 456-037 trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Triclinium Clinical Trial Project Management (Pty) Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec032958">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-27"></transaction-date>
   <value currency="USD" value-date="2016-10-27">39015.66</value>
   <description>
    <narrative xml:lang="EN">PBMC Lab for 972-041 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="15">
    <narrative xml:lang="EN">Kenya Medical Research Institute (KEMRI)</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec032934">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-28"></transaction-date>
   <value currency="USD" value-date="2016-10-28">9910.53</value>
   <description>
    <narrative xml:lang="EN">PBMC, Whole Blood, Paxgene for 972-041 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aurum Institute NPC, South Africa</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec033019">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-01-17"></transaction-date>
   <value currency="USD" value-date="2017-01-17">34986.6</value>
   <description>
    <narrative xml:lang="EN">Participants costs for the T18 trial (total paid was $ 69,973.20, of that, half was charged to DFID and another half to other funder)</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Setshaba Research Centre</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec033217">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-01-21"></transaction-date>
   <value currency="USD" value-date="2016-01-21">365.32</value>
   <description>
    <narrative xml:lang="EN">Payment to ICON (Clinical Research Organization) for the A042 trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">ICON</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec033159">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-12-15"></transaction-date>
   <value currency="USD" value-date="2016-12-15">5705.2</value>
   <description>
    <narrative xml:lang="EN">Payment to ICON (Clinical Research Organization) for the A042 trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="70">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">ICON</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef057935">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-02-07"></transaction-date>
   <value currency="USD" value-date="2014-02-07">100000</value>
   <description>
    <narrative xml:lang="EN">Primate Study</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Tianjin CanSino Biotechnology Inc</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef063195-96">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-12-17"></transaction-date>
   <value currency="USD" value-date="2014-12-17">35752.5</value>
   <description>
    <narrative xml:lang="EN">Regulatory Expenses for C02-045 Trial</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Triclinium Clinical Trial Project Management (Pty) Ltd</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="GJ#011354">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-07-08"></transaction-date>
   <value currency="USD" value-date="2016-07-08">50029</value>
   <description>
    <narrative xml:lang="EN">STING-Activating Adjuvant Vaccines for Tuberculosis</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">University of California</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="PORec033031">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-11-10"></transaction-date>
   <value currency="USD" value-date="2016-11-10">38922.85</value>
   <description>
    <narrative xml:lang="EN">Screen failures for Klerksdorp site for T18 trial (the total payment was $77.845.70 and half of that was charged to DFID and anther half to another funder)</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aurum Institute NPC, South Africa</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="SA2013Internal">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2013-12-31"></transaction-date>
   <value currency="USD" value-date="2013-12-31">727103</value>
   <description>
    <narrative xml:lang="EN">South Africa location cost - this includes staffing, travel, consulting, and supplies costs</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="SA2014Internal">
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2014-12-31"></transaction-date>
   <value currency="USD" value-date="2014-12-31">736867.92</value>
   <description>
    <narrative xml:lang="EN">South Africa location cost for FY 2014- this includes staffing, travel, consulting, and supplies costs</narrative>
   </description>
   <provider-org ref="US-EIN-522044704" type="21">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
  </transaction>
  <transaction ref="Invoice Number 227962.1">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-06"></transaction-date>
   <value currency="USD" value-date="2017-12-29">105494.4</value>
   <description>
    <narrative xml:lang="EN">Study 905-N04</narrative>
   </description>
  </transaction>
  <transaction ref="Invoice Number 227060.01">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-12-29"></transaction-date>
   <value currency="USD" value-date="2017-12-29">272610</value>
   <description>
    <narrative xml:lang="EN">Study 905-N04</narrative>
   </description>
  </transaction>
  <transaction ref="Invoice Number 6239504">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-02-19"></transaction-date>
   <value currency="USD" value-date="2018-02-19">22662.9</value>
   <description>
    <narrative xml:lang="EN">Subject visits Mar - Jun 2017</narrative>
   </description>
   <receiver-org ref="University of Cape Town" type="80"></receiver-org>
  </transaction>
  <transaction ref="GJ#011085">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-09-16"></transaction-date>
   <value currency="USD" value-date="2016-09-16">250000</value>
   <description>
    <narrative xml:lang="EN">TB Vaccine Research and Development through Partnership with TuBerculosis Vaccine Initiative (TBVI)</narrative>
   </description>
   <provider-org ref="US-EIN-522044704">
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Stichting TuBerculosis Vaccine Initiative (TBVI)</narrative>
   </receiver-org>
  </transaction>
  <transaction humanitarian="0" ref="APRef307562">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-01-10"></transaction-date>
   <value currency="USD" value-date="2014-01-10">1900</value>
   <description>
    <narrative xml:lang="EN">Total check was for $ 22,316. Of that $1,900 was charged to DFID.</narrative>
   </description>
   <provider-org>
    <narrative xml:lang="EN">Aeras</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Quintiles Ltd.</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="Invoice Number 227060.02">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-01"></transaction-date>
   <value currency="USD" value-date="2017-12-29">162639.5</value>
   <provider-org ref="Study 905-N04"></provider-org>
  </transaction>
 </iati-activity>
</iati-activities>
